Blue light used to harden tooth fillings stunts tumor growth

June 25, 2008

A blue curing light used to harden dental fillings also may stunt tumor growth, Medical College of Georgia researchers say.

"The light sends wavelengths of blue-violet light to the composite, which triggers hardening," says Alpesh Patel, a rising MCG School of Dentistry junior. "The light waves produce free radicals that activate the catalyst and speed up polymerization of the composite resin. In oral cancer cells, though, those radicals cause damage that decreases cell growth and increases cell death."

Mr. Patel, who has been working with Dr. Jill Lewis, associate professor of oral biology, Dr. Regina Messer, associate professor of oral rehabilitation and oral biology, and Dr. John Wataha, adjunct professor of oral rehabilitation and oral biology, studied 10 tumor-bearing mice, five treated with the light and five untreated.

He exposed half the mice to the blue light for 90 seconds a day for 12 days. Then the tumors were extracted and each one was split into two sections. Half were used to create slides for tissue analysis, and half were frozen to prepare protein extracts.

Tissue analysis indicated an approximate 10 percent increase in cell suicide, or apoptosis, in the light-treated tumors. The frozen protein extracts revealed a nearly 80 percent decrease in cell growth in the light-treated tumors.

"The decrease in cell growth, combined with increased apoptosis, helps explain why the tumors didn't grow as much because you have cells that aren't dividing and you have cells that are committing suicide," Mr. Patel says.

Dr. Lewis predicts treating the tumors with blue light sooner will increase the rate of apoptosis, possibly preventing the tumor from ever becoming measurable and easing treatment.

"One desirable feature we've observed with the blue light is that non-cancerous cells appear unaffected at light doses that kill tumor cells," says Dr. Lewis. "We're thinking that some day, blue light therapy may serve as an adjunct to conventional cancer therapy. Patients may, therefore, receive lower doses of chemotherapy, which would decrease the adverse effects most cancer patients experience from standard chemotherapy regimens."

Medical College of Georgia

---

---

	Cancer Immunotherapy: Immune Suppression and Tumor Growth by George C. Prendergast (Editor), Elizabeth M. Jaffee (Editor) There has been major growth in understanding immune suppression mechanisms and its relationship to cancer progression and therapy. This book highlights emerging new principles of immune suppression that drive cancer and it offers radically new ideas about how therapy can be improved by attacking these principles. Following work that firmly establishes immune escape as an essential trait of cancer, recent studies have now defined specific mechanisms of tumoral immune suppression. It also demonstrates how attacking tumors with molecular targeted therapeutics or traditional chemotherapeutic drugs can produce potent anti-tumor effects in preclinical models. This book provides basic, translational, and clinical cancer researchers an indispensable overview of immune escape as a critical trait...
	Membranes In Tumor Growth (Developments in Cancer Research) by Galleotti (Author)
	Regulation of Gene Expression in the Tumor Environment: Regulation of melanoma progression by the microenvironment: the roles of PAR-1 and PAFR (The Tumor Microenvironment) by Menashe Bar-Eli (Editor) It is now becoming very clear that the development and progression of tumor towards the malignant (metastatic) phenotype depends tightly on the interaction between the tumor cells and the tumor microenvironment. Tumor cells respond to stimuli generated within the tumor microenvironment for their growth advantage while the tumor cell themselves reshape and remodel the architecture and function of their extracellular matrices. The term tumor microenvironment is a wide umbrella consisting of stromal cells such as fibroblasts and endothelial cells and infiltration immune cells including T and B cells, macrophages, and other inflammatory cells (PMNs). These different components of the tumor microenvironment could have stimulatory and inhibitory effects on tumor progression by regulating the...
	Growth Regulation of Thyroid Gland and Thyroid Tumors (Frontiers of Hormone Research) by P. E. Goretzki (Author), H. D. Roher (Editor)
	Egf Receptor in Tumor Growth and Progression (Ernst Schering Research Foundation Workshop, 19) by R. B. Lichtner (Editor), R. N. Harkins (Editor) The tyrosine kinases are frequently implicated in experimental as well as in human cancer. The best-studied receptor signaling system from this family is the EGF receptor. Experts in this area report on the involvement of the receptor in a variety of human tumors, outline underlying molecular mechanisms for aberrant receptor signaling in experimental systems and present the status of current therapies. A detailed analysis of EGF receptor signal transduction via expression of receptor, ligands, phosphatases and presence of other members of the receptor family will provide new information for the design of therapeutic modalities targeting this receptor system.
	Growth Factors and Tumor Promotion: Implications for Risk Assessment by R. Michael McClain (Editor), Thomas J. Slaga (Editor), Robert Le Boeuf (Editor), Henry C. Pitot (Editor) Progress in Clinical and Biological Research, Volume 391 Growth Factors and Tumor Promotion Implications for Risk Assessment R. Michael McClain, Thomas J. Slaga, Robert LeBoeuf, and Henry Pitot, Editors Understanding the biological, cellular, and molecular mechanisms of growth factors in carcinogenesis is essential to predicting tumor development both in research and clinical settings. An up-to-date and much needed overview of this field, Growth Factors and Tumor Promotion: Implications for Risk Assessment presents cutting-edge work from scientists involved in all areas of oncology and cancer biology. The book presents 32 chapters exploring a wide range of specialized topics in this field. Material in the text ranges from the biological changes caused by growth factors to quantifying...
	Influence of Tumor Development on the Host (Cancer Growth and Progression) by L.A. Liotta (Editor) X
	Influence of the Host on Tumor Development (Cancer Growth and Progression) by Ronald B. Herberman (Editor) X
	Role of Prostate-Specific Antigen (PSA) in Pathological Angiogenesis and Prostate Tumor Growth (Cancer Etiology, Diagnosis and Treatments) by Ravikumar Aalinkeel (Author), Stanley A. Schwartz (Author), B. Bindukumar (Author), Gary J. Smith (Author), Kailash C. Chadha (Author) Prostate specific antigen (PSA) is a serine protease present in an enzymatically inactive form in human serum at a concentration of nanograms/ml; serum PSA (S-PSA) is used widely as a surrogate marker in the diagnosis and management of prostate cancer (CaP). However, the vast majority of PSA produced in the prostate is secreted as active enzyme into the seminal fluid or is sequestered within the prostate tissue microenvironment. This book examines the role of the prostate-specific antigen in prostate tumour growth.
	Tumor Biology: Regulation of Cell Growth, Differentiation and Genetics in Cancer (NATO ASI Series / Cell Biology) by Asterios S. Tsiftsoglou (Editor), Alan C. Sartorelli (Editor), David E. Housman (Editor), T. Michael Dexter (Editor) This book provides both basic aspects and the latest findings in the molecular and cellular biology of malignant tumors. The focus is on the mechanisms by which normal and neoplastic cells proliferate, differentiate and undergo apoptosis. The differentiation of hemopoietic, epithelial and neuronal cells is treated with respect to growth factors, signal transduction, transcription factors, and genes regulating the cell cycle and the commitment to maturation. The role of oncogenes in neoplastic cell growth and cell death is also covered. The book deals with the regulation of globin gene expression by the LCR locus and the mechanisms of RNA stability for iron-binding and other proteins. The induction of differentiation of neoplastic cells as an alternative approach to cancer therapy is...